UK Companies House feature
INVITRO GENETICS LIMITED
Cash
£479K
-57.8% vs 2021
Net assets
£290K
-45.3% vs 2021
Employees
27
+8% vs 2021
Profit before tax
-£348K
-276.9% vs 2021
Profile
- Company number
- 09901425
- Status
- Active
- Incorporation
- 2015-12-03
- Last accounts made up
- 2024-10-31
- Account category
- FULL
- Primary SIC
- 86220
- Hubs
- UK Healthcare
Net assets
5-year trend · vs UK Healthcare median
Accounts
5-year trend · latest 2022-10-31
| Metric | Trend | 2018-10-31 | 2019-10-31 | 2020-10-31 | 2021-10-31 | 2022-10-31 |
|---|---|---|---|---|---|---|
| Turnover | — | — | — | £5,523,656 | £5,731,802 | |
| Operating profit | — | — | — | £226,235 | -£326,955 | |
| Profit before tax | — | — | — | £196,915 | -£348,316 | |
| Net profit | — | — | — | £68,691 | -£240,200 | |
| Cash | — | — | — | £1,134,841 | £479,442 | |
| Total assets less current liabilities | — | — | — | £572,612 | £317,179 | |
| Net assets | — | — | — | £530,382 | £290,182 | |
| Equity | £2,500,303 | £1,460,154 | £461,691 | £530,382 | £290,182 | |
| Average employees | — | — | — | 25 | 27 | |
| Wages | — | — | — | £1,753,796 | £1,635,800 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PKF Francis Clark
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis which the directors consider to be appropriate for the following reasons. The Cooper Companies has indicated its intention to make available funding to cover intercompany and other external liabilities for the companies, this includes agreeing that intercompany creditor balances will not be called in within 12 months from the date of the approval of the financial statements, unless the company is in a position to be able to repay this balance. This financial support will continue in place for at least a period covering 12 months from the date of the approval of these financial statements. Consequently, the directors are confident that the company will have sufficient funds to continue to meet its liabilities as they fall due for at least 12 months from the date of approval of the financial statements and therefore have prepared the financial statements on a going concern basis.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ANDREWS, Brian George | Director | 2018-08-08 | May 1978 | American |
| PENFOLD, Nigel Anton | Director | 2025-02-05 | Sep 1972 | British |
| RICUPATI, Agostino | Director | 2017-10-02 | Jan 1967 | American |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| AUERBACH, Robert Dave | Director | 2015-12-14 | 2018-08-08 |
| BLAIR, Kerry Lee | Director | 2017-04-26 | 2018-08-08 |
| CALCAGNO, John Joseph | Director | 2019-03-15 | 2025-02-05 |
| GOLDEN, Randal Louis | Director | 2018-08-08 | 2020-04-30 |
| HANSEN, David Truels | Director | 2017-04-18 | 2021-03-30 |
| HVIDKJAER, Jeannett | Director | 2017-04-18 | 2018-05-16 |
| III, Albert George White | Director | 2017-01-31 | 2017-10-02 |
| KAUFMAN, Carol Rose | Director | 2015-12-03 | 2018-08-08 |
| MATZ, Gregory Wayne | Director | 2015-12-03 | 2017-01-31 |
| TUCKER, Alan Thompson | Director | 2018-08-08 | 2019-03-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Coopersurgical Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 54 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-08-01 | AA | accounts | accounts with accounts type full |
| 2025-07-08 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-07-01 | CH01 | officers | change person director company with change date |
| 2025-03-18 | CH01 | officers | change person director company with change date |
| 2025-02-05 | AP01 | officers | appoint person director company with name date |
| 2025-02-05 | TM01 | officers | termination director company with name termination date |
| 2024-08-05 | AA | accounts | accounts with accounts type full |
| 2024-07-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-10-30 | AA | accounts | accounts with accounts type full |
| 2023-07-18 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-07-27 | AA | accounts | accounts with accounts type full |
| 2022-07-08 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-10-27 | AA | accounts | accounts with accounts type full |
| 2021-07-08 | CS01 | confirmation-statement | confirmation statement with updates |
| 2021-04-06 | TM01 | officers | termination director company with name termination date |
| 2020-12-30 | SH01 | capital | capital allotment shares |
| 2020-11-05 | AA | accounts | accounts with accounts type full |
| 2020-07-30 | CH01 | officers | change person director company with change date |
| 2020-07-21 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-05-13 | TM01 | officers | termination director company with name termination date |
Credit score
Altman Z″ (private-firm) · reference 2022-10-31
-2.29
DISTRESS
Altman Z″
- Working capital / Total assets -0.275 × 6.56 = -1.81
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets -0.084 × 6.72 = -0.57
- Book equity / Total liabilities 0.081 × 1.05 = +0.08
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory